From Tradeoffs to Triumphs: Launching Lean and Effective With a Modern Data Strategy

Session details:

Since 2012, a third of all pharma launches missed expectations, and 40% missed two-year forecasts. But with a tight budget, what are your options when standing up early launch capabilities to remedy these tough statistics? Learn how others used an integrated, sequenced approach to data to win the efficiency game and maximize their pre-launch budgets. 

Case studies will include:

• How an emerging biopharma with a shortened timeline beat forecasts in rare disease by staging targeting efforts
• How a mid-size pharma accelerated a label-expansion launch through MSL activation
• How one top 20 pharma navigated an inherited forecast and poor GTM strategy from M&A

If you’re involved in standing up early medical and commercial capabilities, don’t miss these practical real-world examples to ensure that you hit your milestones in today’s launch environment.